Pfizer Inc. recalls Duavee (conjugated estrogens/bazedoxifene) tablets 0.45/20 mg, packaged in 2 blister cards containing 15 tablets each (…

Recall date

May 27, 2020

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-1342-2020

FDA classification

Class III

Brand / firm

Pfizer Inc.

Sold / distributed

Nationwide within the United States

Why it was recalled

Failed Dissolution Specifications

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

Duavee (conjugated estrogens/bazedoxifene) tablets 0.45/20 mg, packaged in 2 blister cards containing 15 tablets each (30 tablets), Rx Only, Distributed by Wyeth Pharmaceuticals LLC A subsidiary of Pfizer In Philadelphia, PA 19101 Made in Ireland, NDC 00008-1123-12